-
1 . Academic Journal
Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study
- 저자
- by Cahn, Pedro Enrique; Cassetti, Lidia Isabel; Porteiro Barreira, Norma; Angel, Jonathan Benjamin; de Pokomandy, Alexandra, et al.
- 소스
- In The Lancet HIV December 2017 4(12):e536-e546
-
7 . Periodical
Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study
- 저자
- by Orrell, Catherine; Hagins, Debbie P; Belonosova, Elena; Porteiro, Norma; Walmsley, Sharon, et al.
- 소스
- The Lancet HIV; December 2017, Vol. 4 Issue: 12 pe536-e546, 11p